{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:39:59Z","timestamp":1790782799993,"version":"4.1.0"},"reference-count":266,"publisher":"Impact Journals, LLC","issue":"37","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,9,5]]},"DOI":"10.18632\/oncotarget.18337","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T04:18:34Z","timestamp":1496377114000},"page":"60727-60749","source":"Crossref","is-referenced-by-count":33,"title":["Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen"],"prefix":"10.18632","volume":"8","author":[{"given":"Richard E.","family":"Kast","sequence":"first","affiliation":[{"name":"IIAIGC Study Center, Burlington, VT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Skuli","sequence":"additional","affiliation":[{"name":"INSERM, Centre de Recherches en Canc\u00e9rologie de Toulouse, CRCT, Inserm\/Universit\u00e9 Toulouse III, Paul Sabatier, Hubert Curien, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Karpel-Massler","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ulm University Hospital, Albert-Einstein-Allee, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Frosina","sequence":"additional","affiliation":[{"name":"Mutagenesis & Cancer Prevention Unit, IRCCS Azienda Ospedaliera Universitaria San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Largo Rosanna Benzi, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Ryken","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Kansas, Lawrence, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Eric","family":"Halatsch","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ulm University Hospital, Albert-Einstein-Allee, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,6,1]]},"reference":[{"key":"1","article-title":"EMT, cell plasticity and metastasis","author":"Weinberg","year":"2016","journal-title":"Cancer Metastasis Rev"},{"key":"2","doi-asserted-by":"publisher","first-page":"62767","DOI":"10.18632\/oncotarget.11232","article-title":"AKT-ions with a TWIST between EMT and MET","volume":"7","author":"Xue","year":"2016","journal-title":"Oncotarget"},{"key":"3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4161\/19336918.2014.983794","article-title":"Reprogramming during epithelial to mesenchymal transition under the control of TGFbeta","volume":"9","author":"Moustakas","year":"2015","journal-title":"Cell Adh Migr"},{"key":"4","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/stem.2406","article-title":"Concise Review: Stem Cells and Epithelial Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets","volume":"3","author":"Arima","year":"2016","journal-title":"Stem Cells"},{"key":"5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/1878-0261.12017","article-title":"Epithelial-mesenchymal transition in tumor metastasis","volume":"1","author":"Yang","year":"2017","journal-title":"Mol Oncol"},{"key":"6","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.3892\/ijo.2015.2944","article-title":"Epithelial to mesenchymal transition in paired human primary and recurrent glioblastomas","volume":"4","author":"Held-Feindt","year":"2015","journal-title":"Int J Oncol"},{"key":"7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3727\/096504016X14737243054982","article-title":"Isolation and characterization of fast migrating human glioma cells in the progression of malignant gliomas","volume":"2","author":"Held-Feindt","year":"2017","journal-title":"Oncol Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s12015-011-9283-1","article-title":"Cancer-initiating enriched cell lines from human glioblastoma: Preparing for drug discovery assays","volume":"8","author":"Ayuso-Sacido","year":"2012","journal-title":"Stem Cell Rev"},{"key":"9","first-page":"479","article-title":"Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019","volume":"13","author":"Mascelli","year":"2014","journal-title":"Int J Cancer"},{"key":"10","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/neuonc\/nou362","article-title":"ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells","volume":"1","author":"Yong","year":"2015","journal-title":"Neuro Oncol"},{"key":"11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13045-016-0307-9","article-title":"Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma","volume":"9","author":"Steel","year":"2016","journal-title":"J Hematol Oncol"},{"key":"12","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3892\/ol.2016.4113","article-title":"Epithelial-mesenchymal transition in glioblastoma progression","volume":"1","author":"Iwadate","year":"2016","journal-title":"Oncol Lett"},{"key":"13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11060-016-2145-6","article-title":"Transforming growth factor-beta and stem cell markers are highly expressed around necrotic areas in glioblastoma","volume":"12","author":"Saeki","year":"2016","journal-title":"J Neurooncol"},{"key":"14","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/mc.20541","article-title":"Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling","volume":"4","author":"B\u00e9liveau","year":"2009","journal-title":"Mol Carcinog"},{"key":"15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.bbrc.2011.02.123","article-title":"Elevated invasive potential of glioblastoma stem cells","volume":"40","author":"Bao","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits","volume":"9","author":"Weinberg","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/med.21408","article-title":"The Epithelial-to-Mesenchymal Transition-Like Process in Glioblastoma: An Updated Systematic Review and In Silico Investigation","volume":"3","author":"Wink","year":"2017","journal-title":"Med Res Rev"},{"key":"18","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.1158\/0008-5472.CAN-09-4613","article-title":"Epithelial-to-mesenchymal transition promotes tubulin detyrosination and microtentacles that enhance endothelial engagement","volume":"7","author":"Martin","year":"2010","journal-title":"Cancer Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/neuonc\/not024","article-title":"Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis","volume":"1","author":"Yung","year":"2013","journal-title":"Neuro Oncol"},{"key":"20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/molecules21070965","article-title":"Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer","author":"Shim","year":"2016","journal-title":"Molecules"},{"key":"21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/cancers4020523","article-title":"Epidermal to Mesenchymal Transition and Failure of EGFR-Targeted Therapy in Glioblastoma","volume":"4","author":"Halatsch","year":"2012","journal-title":"Cancers (Basel)"},{"key":"22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/ijms17081308","article-title":"The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells","author":"Andergassen","year":"2016","journal-title":"Int J Mol Sci"},{"key":"23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00432-014-1752-x","article-title":"The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells","volume":"14","author":"Yin","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"24","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.18632\/oncotarget.12242","article-title":"Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion","volume":"8","author":"Gires","year":"2017","journal-title":"Oncotarget"},{"key":"25","first-page":"95","article-title":"Iron Overload Causes Alterations of E-Cadherin in the Liver","volume":"6","author":"Necas","year":"2016","journal-title":"Folia Biol (Praha)"},{"key":"26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.14670\/HH-30.361","article-title":"N-cadherin, beta-catenin and connexin 43 expression in astrocytic tumours of various grades","volume":"3","author":"Chyczewski","year":"2015","journal-title":"Histol Histopathol"},{"key":"27","first-page":"187","article-title":"Relationship between the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas","volume":"5","author":"Fujii","year":"2002","journal-title":"J Neurooncol"},{"key":"28","first-page":"1397","article-title":"Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter","volume":"9","author":"Pal","year":"2016","journal-title":"J Mol Med (Berl)"},{"key":"29","first-page":"15333","article-title":"Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients","volume":"3","author":"Jiang","year":"2016","journal-title":"Tumour Biol"},{"key":"30","first-page":"222","article-title":"MicroRNAs in glioblastoma: role in pathogenesis and opportunities for targeted therapies","volume":"1","author":"de Lima","year":"2015","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"31","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3892\/or.2015.4432","article-title":"MicroRNA-663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF-\u03b21","volume":"3","author":"Jiang","year":"2016","journal-title":"Oncol Rep"},{"key":"32","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.bbrc.2015.12.021","article-title":"MicroRNA-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-\u03b2 pathway","volume":"46","author":"Yu","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"33","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/j.1582-4934.2011.01285.x","article-title":"Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal","volume":"1","author":"Gazzaniga","year":"2011","journal-title":"J Cell Mol Med"},{"key":"34","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1158\/2159-8290.CD-14-0471","article-title":"Brain tumor cells in circulation are enriched for mesenchymal gene expression","volume":"4","author":"Iafrate","year":"2014","journal-title":"Cancer Discov"},{"key":"35","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2176\/nmc.ra.2016-0077","article-title":"Phenotypic Transition as a Survival Strategy of Glioma","volume":"5","author":"Date","year":"2016","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"36","doi-asserted-by":"publisher","first-page":"7979","DOI":"10.1038\/srep07979","article-title":"The evidence of glioblastoma heterogeneity","volume":"5","author":"Park","year":"2015","journal-title":"Sci Rep"},{"key":"37","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1158\/1078-0432.CCR-15-2089","article-title":"Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma","volume":"2","author":"Sch\u00e4fer","year":"2017","journal-title":"Clin Cancer Res"},{"key":"38","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10585-009-9260-0","article-title":"Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma","volume":"2","author":"Krauss","year":"2009","journal-title":"Clin Exp Metastasis"},{"key":"39","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.yexcr.2012.07.017","article-title":"Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications","volume":"31","author":"Wang","year":"2012","journal-title":"Exp Cell Res"},{"key":"40","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.ajpath.2012.01.040","article-title":"The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma","volume":"18","author":"Brat","year":"2012","journal-title":"Am J Pathol"},{"key":"41","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/neuonc\/nos158","article-title":"Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype","volume":"1","author":"de Groot","year":"2012","journal-title":"Neuro Oncol"},{"key":"42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.canlet.2015.01.010","article-title":"Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1\u03b1-ZEB1 axis","volume":"35","author":"Kruyt","year":"2015","journal-title":"Cancer Lett"},{"key":"43","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1007\/s12035-015-9340-x","article-title":"CXCL12\/CXCR4 Axis Upregulates Twist to Induce EMT in Human Glioblastoma","volume":"5","author":"Wu","year":"2016","journal-title":"Mol Neurobiol"},{"key":"44","doi-asserted-by":"publisher","first-page":"156","DOI":"10.18632\/oncoscience.311","article-title":"Durable response of glioblastoma to adjuvant therapy consisting of temozolomide and a weekly dose of AMD3100 (plerixafor), a CXCR4 inhibitor, together with lapatinib, metformin and niacinamide","volume":"3","author":"Brown","year":"2016","journal-title":"Oncoscience"},{"key":"45","doi-asserted-by":"publisher","first-page":"11664","DOI":"10.18632\/oncotarget.3256","article-title":"Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway","volume":"6","author":"Chinot","year":"2015","journal-title":"Oncotarget"},{"key":"46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.canlet.2015.02.005","article-title":"VEGFR inhibitors upregulate CXCR4 in VEGF receptor-expressing glioblastoma in a TGF\u03b2R signaling-dependent manner","volume":"36","author":"Harrison","year":"2015","journal-title":"Cancer Lett"},{"key":"47","doi-asserted-by":"publisher","first-page":"84190","DOI":"10.18632\/oncotarget.12391","article-title":"Metformin potentiates anti-tumor effect of resveratrol on pancreatic cancer by down-regulation of VEGF-B signaling pathway","volume":"7","author":"Qi","year":"2016","journal-title":"Oncotarget"},{"key":"48","doi-asserted-by":"publisher","first-page":"44579","DOI":"10.18632\/oncotarget.6373","article-title":"Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2\/HIF-1\u03b1\/VEGF secretion axis","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2014.08.012","article-title":"The anti-diabetic drug metformin inhibits vascular endothelial growth factor expression via the mammalian target of rapamycin complex 1\/hypoxia-inducible factor-1\u03b1 signaling pathway in ELT-3 cells","volume":"39","author":"Yaegashi","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"50","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.metabol.2013.07.004","article-title":"Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment","volume":"6","author":"Henry","year":"2013","journal-title":"Metabolism"},{"key":"51","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.diabres.2008.02.006","article-title":"The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients","volume":"8","author":"Imamoglu","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"52","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/cen.12950","article-title":"Serum vascular endothelial growth factor B is elevated in women with polycystic ovary syndrome and can be decreased with metformin treatment","volume":"8","author":"Liu","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"53","first-page":"v190","article-title":"ESMO Guidelines Working Group. High-grade malignant glioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"2","author":"Pentheroudakis","year":"2010","journal-title":"Ann Oncol"},{"key":"54","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00441-016-2464-0","article-title":"Epithelial mesenchymal transition in tissue repair and fibrosis","volume":"36","author":"Tomic-Canic","year":"2016","journal-title":"Cell Tissue Res"},{"key":"55","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.neo.2014.09.004","article-title":"Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model","volume":"1","author":"Marcato","year":"2014","journal-title":"Neoplasia"},{"key":"56","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/imm.12647","article-title":"M2 polarization of murine peritoneal macrophages induces regulatory cytokine production and suppresses T-cell proliferation","volume":"14","author":"Sugimoto","year":"2016","journal-title":"Immunology"},{"key":"57","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/icb.2016.34","article-title":"Human macrophages induce CD4(+)Foxp3(+) regulatory T cells via binding and re-release of TGF-beta","volume":"9","author":"Tegn\u00e9r","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"58","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s10549-016-3839-3","article-title":"Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation","volume":"15","author":"Rincon","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"59","first-page":"557","article-title":"Frequency of PSA-mRNA-bearing cells in the peripheral blood of patients after prostate biopsy","volume":"8","author":"Takahashi","year":"2001","journal-title":"Br J Cancer"},{"key":"60","first-page":"315","article-title":"Reverse transcriptase polymerase chain reaction study to evaluate dissemination of cancer cells into circulation after incision biopsy in oral squamous cell carcinoma","volume":"1","author":"Hallikerimath","year":"2008","journal-title":"Indian J Dent Res"},{"key":"61","first-page":"303","article-title":"Dissemination of cancer cells into circulation occurs by incisional biopsy of oral squamous cell carcinoma","volume":"2","author":"Kameyama","year":"2000","journal-title":"J Oral Pathol Med"},{"key":"62","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3727\/096504016X14737243054982","article-title":"Isolation and characterization of fast migrating human glioma cells in the progression of malignant gliomas","volume":"2","author":"Held-Feindt","year":"2017","journal-title":"Oncol Res"},{"key":"63","first-page":"2575","article-title":"Overexpression of Snail accelerates adriamycin induction of multidrug resistance in breast cancer cells","volume":"1","author":"Lv","year":"2011","journal-title":"Asian Pac J Cancer Prev"},{"key":"64","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1158\/1078-0432.CCR-08-2372","article-title":"Twist1 mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells","volume":"1","author":"Xu","year":"2009","journal-title":"Clin Cancer Res"},{"key":"65","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.bbrc.2016.09.167","article-title":"Doxorubicin-induced epithelial-mesenchymal transition through SEMA 4A in hepatocellular carcinoma","volume":"47","author":"Ye","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"66","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.canlet.2016.04.026","article-title":"ARK5 promotes doxorubicin resistance in hepatocellular carcinoma via epithelial-mesenchymal transition","volume":"37","author":"Bai","year":"2016","journal-title":"Cancer Lett"},{"key":"67","first-page":"3921","article-title":"COUP-TFII suppresses colorectal carcinoma resistance to doxorubicin involving inhibition of epithelial mesenchymal transition","volume":"8","author":"Bao","year":"2016","journal-title":"Am J Transl Res"},{"key":"68","first-page":"2512","article-title":"miR-223\/FBW7 axis regulates doxorubicin sensitivity through epithelial mesenchymal transition in non-small cell lung cancer","volume":"8","author":"Li","year":"2016","journal-title":"Am J Transl Res"},{"key":"69","first-page":"4271","article-title":"An epigenetic mechanism underlying doxorubicin induced EMT in the human BGC-823 gastric cancer cell","volume":"1","author":"Zhang","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"70","doi-asserted-by":"publisher","first-page":"22077","DOI":"10.18632\/oncotarget.7895","article-title":"The TGF-\u03b2 pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells","volume":"7","author":"Grassilli","year":"2016","journal-title":"Oncotarget"},{"key":"71","first-page":"6434","article-title":"Formononetin sensitizes glioma cells to doxorubicin through preventing EMT via inhibition of histone deacetylase 5","volume":"8","author":"Huang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"72","first-page":"4147","article-title":"Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines","volume":"1","author":"Ellis","year":"2006","journal-title":"Clin Cancer Res"},{"key":"73","first-page":"277","article-title":"Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells","volume":"3","author":"Kikkawa","year":"2007","journal-title":"Int J Oncol"},{"key":"74","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.18632\/oncotarget.2088","article-title":"A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway","volume":"5","author":"Fu","year":"2014","journal-title":"Oncotarget"},{"key":"75","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.critrevonc.2014.05.006","article-title":"Radiation-enhanced cell migration\/invasion process: a review","volume":"9","author":"Magn\u00e9","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"76","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-016-0577-4","article-title":"Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation","volume":"1","author":"Kang","year":"2017","journal-title":"Mol Cancer"},{"key":"77","doi-asserted-by":"publisher","first-page":"14259","DOI":"10.18632\/oncotarget.7423","article-title":"BK K+ channel blockade inhibits radiation induced migration\/brain infiltration of glioblastoma cells","volume":"7","author":"Huber","year":"2016","journal-title":"Oncotarget"},{"key":"78","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1684\/bdc.2014.1946","article-title":"Radiation-induces increased tumor cell aggressiveness of tumors of the glioblastomas","volume":"10","author":"Magn\u00e9","year":"2014","journal-title":"Bull Cancer"},{"key":"79","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cellsig.2016.10.012","article-title":"Cathepsin L is involved in X-ray-induced invasion and migration of human glioma U251 cells","volume":"2","author":"Liang","year":"2017","journal-title":"Cell Signal"},{"key":"80","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/jrr\/rrt119","article-title":"Proton beam irradiation stimulates migration and invasion of human U87 malignant glioma cells","volume":"5","author":"Matsumura","year":"2014","journal-title":"J Radiat Res"},{"key":"81","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1073\/pnas.1616100114","article-title":"Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9\/Syntenin","volume":"11","author":"Purves","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"82","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/neuonc\/not239","article-title":"Sustained elevation of Snail promotes glial mesenchymal transition after irradiation in malignant glioma","volume":"1","author":"Tanaka","year":"2014","journal-title":"Neuro Oncol"},{"key":"83","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1080\/09553002.2016.1175682","article-title":"Infiltration of F98 glioma cells in Fischer rat brain is temporary stimulated by radiation","volume":"9","author":"Paquette","year":"2016","journal-title":"Int J Radiat Biol"},{"key":"84","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bbrc.2011.07.074","article-title":"Low doses ionizing radiation enhances the invasiveness of breast cancer cells by inducing epithelial-mesenchymal transition","volume":"41","author":"Moran","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"85","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3892\/or.2011.1485","article-title":"Radiation induces epithelial-mesenchymal transition in colorectal cancer cells","volume":"2","author":"Kusunoki","year":"2012","journal-title":"Oncol Rep"},{"key":"86","first-page":"89","article-title":"Increased motility and invasiveness in tumor cells that survive 10 Gy irradiation","volume":"3","author":"Ohba","year":"2009","journal-title":"Cell Struct Funct"},{"key":"87","doi-asserted-by":"publisher","first-page":"71390","DOI":"10.18632\/oncotarget.12111","article-title":"X-radiation enhances the collagen type I strap formation and migration potentials of colon cancer cells","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"88","first-page":"500","article-title":"Irradiation induced epithelial-mesenchymal transition (EMT) related to invasive potential in endometrial carcinoma cells","volume":"10","author":"Kikkawa","year":"2007","journal-title":"Gynecol Oncol"},{"key":"89","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3892\/or.2016.4768","article-title":"Ionizing radiation promotes advanced malignant traits in nasopharyngeal carcinoma via activation of epithelial-mesenchymal transition and the cancer stem cell phenotype","volume":"3","author":"Qiu","year":"2016","journal-title":"Oncol Rep"},{"key":"90","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.clcc.2015.09.003","article-title":"Therapy-Induced Cellular Senescence Induces Epithelial-to-Mesenchymal Transition and Increases Invasiveness in Rectal Cancer","volume":"1","author":"Costa","year":"2016","journal-title":"Clin Colorectal Cancer"},{"key":"91","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.ijrobp.2011.06.1956","article-title":"Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial-mesenchymal transition","volume":"8","author":"Guo","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"92","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.resinv.2015.06.001","article-title":"All-case post-marketing surveillance of 1371 patients treated with pirfenidone for idiopathic pulmonary fibrosis","volume":"5","author":"Nukiwa","year":"2015","journal-title":"Respir Investig"},{"key":"93","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1358\/dot.2010.46.7.1488336","article-title":"Pirfenidone in idiopathic pulmonary fibrosis","volume":"4","author":"Maher","year":"2010","journal-title":"Drugs Today (Barc)"},{"key":"94","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/14740338.2016.1187129","article-title":"A safety evaluation of pirfenidone for the treatment of idiopathic pulmonary fibrosis","volume":"1","author":"Nathan","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"95","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/jcm5090078","article-title":"Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis","author":"Chaudhuri","year":"2016","journal-title":"J Clin Med"},{"key":"96","doi-asserted-by":"publisher","first-page":"840","DOI":"10.7150\/ijms.11579","article-title":"Role and New Insights of Pirfenidone in Fibrotic Diseases","volume":"1","author":"Armendariz-Borunda","year":"2015","journal-title":"Int J Med Sci"},{"key":"97","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.semcancer.2016.08.009","article-title":"TGFbeta-induced transcription in cancer","volume":"4","author":"Sanz-Moreno","year":"2017","journal-title":"Semin Cancer Biol"},{"key":"98","doi-asserted-by":"publisher","first-page":"385","DOI":"10.7497\/j.issn.2095-3941.2015.0015","article-title":"Mechanistic basis and clinical relevance of the role o transforming growth factor-\u03b2 in cancer","volume":"1","author":"Zhao","year":"2015","journal-title":"Cancer Biol Med"},{"key":"99","first-page":"499","article-title":"An imbalance between Smad and MAPK pathways is responsible for TGF-beta tumor promoting effects in high-grade gliomas","volume":"3","author":"Hau","year":"2007","journal-title":"Int J Oncol"},{"key":"100","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.celrep.2016.06.045","article-title":"Post-translational Modifications of OLIG2 Regulate Glioma Invasion through the TGF-beta Pathway","volume":"1","author":"Sanai","year":"2016","journal-title":"Cell Rep"},{"key":"101","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.febslet.2015.04.058","article-title":"Transforming growth factor \u03b2 and bone morphogenetic protein actions in brain tumors","volume":"58","author":"Moustakas","year":"2015","journal-title":"FEBS Lett"},{"key":"102","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/978-94-007-4719-7_9","article-title":"TGF beta signaling and its role in glioma pathogenesis","volume":"98","author":"Kijewska","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"103","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00441-016-2474-y","article-title":"The role of integrins in TGF\u03b2 activation in the tumour stroma","volume":"36","author":"Marshall","year":"2016","journal-title":"Cell Tissue Res"},{"key":"104","doi-asserted-by":"publisher","first-page":"408","DOI":"10.2500\/ajra.2015.29.4221","article-title":"Pirfenidone inhibits transforming growth factor beta1-induced extracellular matrix production in nasal polyp-derived fibroblasts","volume":"2","author":"Lee","year":"2015","journal-title":"Am J Rhinol Allergy"},{"key":"105","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3389\/fonc.2014.00358","article-title":"Crosstalk of Oncogenic Signaling Pathways during Epithelial Mesenchymal Transition","volume":"4","author":"Langhans","year":"2014","journal-title":"Front Oncol"},{"key":"106","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.4161\/cc.9.22.14048","article-title":"Metformin against TGFbeta-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis","volume":"9","author":"Menendez","year":"2010","journal-title":"Cell Cycle"},{"key":"107","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejps.2014.02.014","article-title":"Effect of pirfenidone on proliferation, TGF-beta-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts","volume":"5","author":"Vancheri","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"108","first-page":"2626","article-title":"Pirfenidone inhibits migration, differentiation, and proliferation of human retinal pigment epithelial cells in vitro","volume":"1","author":"Yu","year":"2013","journal-title":"Mol Vis"},{"key":"109","doi-asserted-by":"publisher","first-page":"e56837","DOI":"10.1371\/journal.pone.0056837","article-title":"Inhibition of pirfenidone on TGF-beta induced proliferation, migration and epithelial-mesenchymal transition of human lens epithelial cells line SRA01\/04","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"key":"110","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/nep.12831","article-title":"Pirfenidone suppresses MAPK signaling pathway to reverse epithelial-mesenchymal transition and renal fibrosis","volume":"2","author":"Gu","year":"2016","journal-title":"Nephrology (Carlton)"},{"key":"111","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2466-12-24","article-title":"Pirfenidone inhibits TGF-beta1 induced over-expression of collagen type I and heat shock protein 47 in A549 cells","volume":"1","author":"Kohno","year":"2012","journal-title":"BMC Pulm Med"},{"key":"112","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bcp.2016.08.002","article-title":"Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-beta signaling in a murine colitis model","volume":"11","author":"Li","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"113","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1002\/stem.2412","article-title":"Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-beta","volume":"3","author":"Chiarugi","year":"2016","journal-title":"Stem Cells"},{"key":"114","doi-asserted-by":"publisher","first-page":"80521","DOI":"10.18632\/oncotarget.11825","article-title":"Hypoxia promotes glioma-associated macrophage infiltration via periostin and subsequent M2 polarization by upregulating TGF-beta and M-CSFR","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"115","first-page":"199","article-title":"Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta","volume":"7","author":"Pilkington","year":"1994","journal-title":"Br J Cancer"},{"key":"116","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.canlet.2016.07.029","article-title":"P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines","volume":"38","author":"Castresana","year":"2016","journal-title":"Cancer Lett"},{"key":"117","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/mc.22575","article-title":"Anthocyanidins inhibit epithelial-mesenchymal transition through a TGF-beta\/Smad2 signaling pathway in glioblastoma cells","volume":"5","author":"Annabi","year":"2017","journal-title":"Mol Carcinog"},{"key":"118","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3892\/or.2013.2505","article-title":"Inhibition of transforming growth factor-\u03b2 release from tumor cells reduces their motility associated with epithelial-mesenchymal transition","volume":"3","author":"Kontani","year":"2013","journal-title":"Oncol Rep"},{"key":"119","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.canlet.2014.05.008","article-title":"Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"35","author":"Wei","year":"2014","journal-title":"Cancer Lett"},{"key":"120","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.2147\/OTT.S100407","article-title":"Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ Regimen","volume":"9","author":"Halatsch","year":"2016","journal-title":"Onco Targets Ther"},{"key":"121","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1471-230X-14-131","article-title":"Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C","volume":"1","author":"Armendariz-Borunda","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"122","first-page":"1010","article-title":"Pirfenidone inhibits transforming growth factor-beta1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19","volume":"1","author":"Choi","year":"2012","journal-title":"Mol Vis"},{"key":"123","first-page":"145","article-title":"Low dose pirfenidone suppresses transforming growth factor beta-1 and tissue inhibitor of metalloproteinase-1, and protects rats from lung fibrosis induced by bleomycin","volume":"2","author":"Zhu","year":"2006","journal-title":"Chin Med Sci J"},{"key":"124","first-page":"542","article-title":"Pirfenidone inhibits TGF-beta expression in malignant glioma cells","volume":"35","author":"Wick","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"125","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s10549-015-3290-x","article-title":"Quetiapine inhibits osteoclastogenesis and prevents human breast cancer-induced bone loss through suppression of the RANKL-mediated MAPK and NF-kB signaling pathways","volume":"14","author":"Chu","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"126","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/cr.2008.84","article-title":"Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells","volume":"1","author":"Chung","year":"2008","journal-title":"Cell Res"},{"key":"127","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1756-9966-32-62","article-title":"Activation of NF-kB by the RANKL\/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines","volume":"3","author":"Nishida","year":"2013","journal-title":"J Exp Clin Cancer Res"},{"key":"128","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1111\/febs.13645","article-title":"RANK as a therapeutic target in cancer","volume":"28","author":"Sanz-Moreno","year":"2016","journal-title":"FEBS J"},{"key":"129","doi-asserted-by":"publisher","first-page":"e108507","DOI":"10.1371\/journal.pone.0108507","article-title":"RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-kB mediated epithelial-mesenchymal transition","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"130","doi-asserted-by":"publisher","first-page":"25328","DOI":"10.18632\/oncotarget.8291","article-title":"CCL20 mediates RANK\/RANKL induced epithelial-mesenchymal transition in endometrial cancer cells","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"key":"131","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.18632\/oncotarget.6795","article-title":"Clinical prognostic significance and pro-metastatic activity of RANK\/RANKL via the AKT pathway in endometrial cancer","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"132","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1148\/radiol.2016160259","article-title":"Radiogenomic Analysis Demonstrates Associations between (18)F-Fluoro-2-Deoxyglucose PET, Prognosis, and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer","volume":"28","author":"Kuo","year":"2016","journal-title":"Radiology"},{"key":"133","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.canlet.2014.07.034","article-title":"Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling","volume":"35","author":"Park","year":"2014","journal-title":"Cancer Lett"},{"key":"134","first-page":"345","article-title":"Rifampin, a useful drug for non-mycobacterial infections","volume":"1","author":"Pien","year":"1998","journal-title":"Pharmacotherapy"},{"key":"135","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10072-012-1156-0","article-title":"Rifampicin and Parkinson\u2019s disease","volume":"3","author":"Tao","year":"2013","journal-title":"Neurol Sci"},{"key":"136","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.brainresbull.2014.05.007","article-title":"RIFAMPICIN: an antibiotic with brain protective function","volume":"10","author":"Schabitz","year":"2014","journal-title":"Brain Res Bull"},{"key":"137","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.3390\/cancers3022050","article-title":"Wnt\/\u03b2-catenin Signaling in Normal and Cancer Stem Cells","volume":"3","author":"Williams","year":"2011","journal-title":"Cancers (Basel)"},{"key":"138","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/onc.2016.304","article-title":"Wnt signaling in cancer","volume":"3","author":"Boutros","year":"2017","journal-title":"Oncogene"},{"key":"139","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/labinvest.2015.140","article-title":"WNT signaling in glioblastoma and therapeutic opportunities","volume":"9","author":"Nam","year":"2016","journal-title":"Lab Invest"},{"key":"140","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1007\/s11481-012-9359-y","article-title":"Wnt\/beta-catenin signaling in glioma","volume":"7","author":"Kang","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"key":"141","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/cancers8090079","article-title":"Wnt5a Signaling in Cancer","author":"Stack","year":"2016","journal-title":"Cancers (Basel)"},{"key":"142","first-page":"3797","article-title":"beta-catenin is a target for the ubiquitin-proteasome pathway","volume":"1","author":"Kemler","year":"1997","journal-title":"EMBO J"},{"key":"143","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3892\/mmr.2016.5971","article-title":"MicroRNA-21 promotes migration and invasion of glioma cells via activation of Sox2 and \u03b2-catenin signaling","volume":"1","author":"Zhang","year":"2017","journal-title":"Mol Med Rep"},{"key":"144","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.3892\/ijo.2016.3415","article-title":"Tetrandrine reverses epithelial-mesenchymal transition in bladder cancer by downregulating Gli-1","volume":"4","author":"Kou","year":"2016","journal-title":"Int J Oncol"},{"key":"145","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3892\/ijo.2016.3780","article-title":"Tetrandrine inhibits glioma stem-like cells by repressing \u03b2-catenin expression","volume":"5","author":"Zhong","year":"2017","journal-title":"Int J Oncol"},{"key":"146","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bbrc.2016.02.120","article-title":"Antibiotic drug rifabutin is effective against lung cancer cells by targeting the eIF4E-beta-catenin axis","volume":"47","author":"Liu","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"147","first-page":"355","article-title":"The expressions of Wnt\/beta-catenin pathway-related components in brainstem gliomas","volume":"4","author":"Zhang","year":"2013","journal-title":"Can J Neurol Sci"},{"key":"148","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/neuonc\/not004","article-title":"miR-92b controls glioma proliferation and invasion through regulating Wnt\/beta-catenin signaling via Nemo-like kinase","volume":"1","author":"Wang","year":"2013","journal-title":"Neuro Oncol"},{"key":"149","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.canlet.2014.11.047","article-title":"ICAT inhibits glioblastoma cell proliferation by suppressing Wnt\/beta-catenin activity","volume":"35","author":"Kang","year":"2015","journal-title":"Cancer Lett"},{"key":"150","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/neuonc\/nos299","article-title":"Wnt\/beta-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells","volume":"1","author":"Nam","year":"2013","journal-title":"Neuro Oncol"},{"key":"151","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jns.2016.05.054","article-title":"Akt and \u03b2-catenin contribute to TMZ resistance and EMT of MGMT negative malignant glioma cell line","volume":"36","author":"Qi","year":"2016","journal-title":"J Neurol Sci"},{"key":"152","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12967-015-0727-2","article-title":"Reversion of malignant phenotypes of human glioblastoma cells by \u03b2-elemene through \u03b2-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related molecules","volume":"1","author":"Liang","year":"2015","journal-title":"J Transl Med"},{"key":"153","first-page":"1268","article-title":"Glioblastoma multiforme formation and EMT: role of FoxM1 transcription factor","volume":"2","author":"Huang","year":"2015","journal-title":"Curr Pharm Des"},{"key":"154","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s00066-015-0858-7","article-title":"Wnt\/beta-catenin pathway involvement in ionizing radiation-induced invasion of U87 glioblastoma cells","volume":"19","author":"Lyu","year":"2015","journal-title":"Strahlenther Onkol"},{"key":"155","doi-asserted-by":"publisher","first-page":"79515","DOI":"10.18632\/oncotarget.12819","article-title":"Deubiquitinase USP9X deubiquitinates beta-catenin and promotes high grade glioma cell growth","volume":"7","author":"Xie","year":"2016","journal-title":"Oncotarget"},{"key":"156","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1097\/NEN.0000000000000227","article-title":"Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells","volume":"7","author":"Eberhart","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"key":"157","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00280-013-2197-7","article-title":"Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines","volume":"7","author":"Gullbo","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"158","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1158\/1535-7163.MCT-13-0052","article-title":"Combined inhibition of HER1\/EGFR and RAC1 results in a synergistic antiproliferative effect on established and primary cultured human glioblastoma cells","volume":"1","author":"Halatsch","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"159","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1158\/0008-5472.CAN-10-4058","article-title":"mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways","volume":"7","author":"Evers","year":"2011","journal-title":"Cancer Res"},{"key":"160","doi-asserted-by":"publisher","first-page":"e0142182","DOI":"10.1371\/journal.pone.0142182","article-title":"Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases","volume":"1","author":"Wandinger-Ness","year":"2015","journal-title":"PLoS One"},{"key":"161","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/bph.12008","article-title":"Interleukins in glioblastoma pathophysiology: implications for therapy","volume":"16","author":"Munoz","year":"2013","journal-title":"Br J Pharmacol"},{"key":"162","doi-asserted-by":"publisher","first-page":"979748","DOI":"10.1155\/2013\/979748","article-title":"Cytokine patterns in brain tumour progression","volume":"201","author":"Tanase","year":"2013","journal-title":"Mediators Inflamm"},{"key":"163","first-page":"367","article-title":"Proteomic analysis of cerebrospinal fluid: toward the identification of biomarkers for gliomas","volume":"3","author":"Zhou","year":"2014","journal-title":"Neurosurg Rev"},{"key":"164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02685897","article-title":"Melanoma inhibition by cyclooxygenase inhibitors: role of interleukin-6 suppression, a putative mechanism of action, and clinical implications","volume":"2","author":"Kast","year":"2007","journal-title":"Med Oncol"},{"key":"165","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0192-0561(00)00046-1","article-title":"Tumor necrosis factor has positive and negative self regulatory feed back cycles centered around cAMP","volume":"2","author":"Kast","year":"2000","journal-title":"Int J Immunopharmacol"},{"key":"166","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10787-006-1532-6","article-title":"Aspirin, TNF-alpha, NFkB, and survival in multiple myeloma: the importance of measuring TNF-alpha","volume":"1","author":"Kast","year":"2006","journal-title":"Inflammopharmacology"},{"key":"167","first-page":"405","article-title":"Interleukin-6 (IL-6) producing phaeochromocytoma: direct IL-6 suppression by non-steroidal anti-inflammatory drugs","volume":"5","author":"Koike","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"168","first-page":"119","article-title":"Effect of naproxen on serum concentrations of IL-I, IL-6, and TNF in patients with osteoarthritis","volume":"4","author":"Mart\u00ednez Zurita","year":"2001","journal-title":"Rev Alerg Mex"},{"key":"169","first-page":"491","article-title":"Can altered production of interleukin-1beta, interleukin-6, transforming growth factor-beta and prostaglandin E(2) by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients","volume":"1","author":"Martel-Pelletier","year":"2002","journal-title":"Osteoarthritis Cartilage"},{"key":"170","first-page":"393","article-title":"Two NSAIDs, nimesulide and naproxen, can reduce the synthesis of urokinase and IL-6 while increasing PAI-1, in human OA synovial fibroblasts","volume":"1","author":"Martel-Pelletier","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"171","first-page":"486","article-title":"Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: effect of the nonsteroidal anti inflammatory drugs indomethacin, diclofenac and naproxen","volume":"4","author":"Panerai","year":"1995","journal-title":"Inflamm Res"},{"key":"172","first-page":"703","article-title":"Left ventricular myxoma presenting with constitutional symptoms and raised serum interleukin-6 both suppressed by naproxen","volume":"1","author":"Murphy","year":"1997","journal-title":"Eur Heart J"},{"key":"173","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s11060-010-0158-0","article-title":"IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines","volume":"10","author":"Zhang","year":"2010","journal-title":"J Neurooncol"},{"key":"174","first-page":"1553","article-title":"IL-6 augments the invasiveness of U87MG human glioblastoma multiforme cells via up-regulation of MMP-2 and fascin-1","volume":"2","author":"Zhang","year":"2010","journal-title":"Oncol Rep"},{"key":"175","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3171\/2008.12.JNS081284","article-title":"Antitumor effect of humanized anti-interleukin-6 receptor antibody (tocilizumab) on glioma cell proliferation. Laboratory investigation","volume":"11","author":"Kuratsu","year":"2009","journal-title":"J Neurosurg"},{"key":"176","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1002\/ijc.29309","article-title":"Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells","volume":"13","author":"Hermans","year":"2015","journal-title":"Int J Cancer"},{"key":"177","first-page":"129","article-title":"Interleukin-1 beta and interleukin-6 mRNA are expressed in human glioblastoma and neuroblastoma cells respectively","volume":"7","author":"Melino","year":"1992","journal-title":"Funct Neurol"},{"key":"178","first-page":"193","article-title":"Interleukin-6 biosynthesis is increased by histamine in human B-cell and glioblastoma cell lines","volume":"7","author":"Falus","year":"1993","journal-title":"Immunology"},{"key":"179","first-page":"669","article-title":"Coexpression of interleukin-1 beta and interleukin-6 in human brain tumors","volume":"3","author":"Libermann","year":"1994","journal-title":"Neurosurgery"},{"key":"180","first-page":"144","article-title":"High and low dose rate irradiation have opposing effects on cytokine gene expression in human glioblastoma cell lines","volume":"3","author":"Redpath","year":"1997","journal-title":"Eur J Cancer"},{"key":"181","doi-asserted-by":"publisher","first-page":"e78728","DOI":"10.1371\/journal.pone.0078728","article-title":"NF-\u03baB-induced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastoma","volume":"8","author":"Nozell","year":"2013","journal-title":"PLoS One"},{"key":"182","first-page":"1837","article-title":"Interleukin-6-mediated autocrine growth promotion in human glioblastoma multiforme cell line U87MG","volume":"7","author":"Sharma","year":"1998","journal-title":"J Neurochem"},{"key":"183","first-page":"4445","article-title":"Interferon-gamma increases IL-6 production in human glioblastoma cell lines","volume":"2","author":"Wolff","year":"2000","journal-title":"Anticancer Res"},{"key":"184","first-page":"518","article-title":"IL-6 gene amplification and expression in human glioblastomas","volume":"8","author":"Verrelle","year":"2001","journal-title":"Br J Cancer"},{"key":"185","first-page":"474","article-title":"Interleukin-6 gene amplification and shortened survival in glioblastoma patients","volume":"9","author":"Verrelle","year":"2007","journal-title":"Br J Cancer"},{"key":"186","first-page":"13","article-title":"Analysis of interleukin-6 gene expression in primary human gliomas, glioblastoma xenografts, and glioblastoma cell lines","volume":"1","author":"Nakazato","year":"2001","journal-title":"Brain Tumor Pathol"},{"key":"187","first-page":"930","article-title":"Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme","volume":"1","author":"Pan","year":"2005","journal-title":"J Clin Neurosci"},{"key":"188","first-page":"13","article-title":"Fas engagement increases expression of interleukin-6 in human glioma cells","volume":"5","author":"Benveniste","year":"2002","journal-title":"J Neurooncol"},{"key":"189","doi-asserted-by":"publisher","first-page":"819","DOI":"10.18632\/oncotarget.13661","article-title":"M2-like tumor-associated macrophages drive vasculogenic mimicry through amplification of IL-6 expression in glioma cells","volume":"8","author":"Qu","year":"2017","journal-title":"Oncotarget"},{"key":"190","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.humimm.2009.03.011","article-title":"Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry","volume":"7","author":"Korkolopoulou","year":"2009","journal-title":"Hum Immunol"},{"key":"191","first-page":"2769","article-title":"IL-8 and IL-6 bystander signalling in human glioblastoma cells exposed to gamma radiation","volume":"3","author":"Nano","year":"2010","journal-title":"Anticancer Res"},{"key":"192","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.bbrc.2009.07.022","article-title":"Aspirin induces apoptosis through the blockade of IL-6-STAT3 signaling pathway in human glioblastoma A172 cells","volume":"38","author":"Bae","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"193","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/stem.188","article-title":"Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth","volume":"2","author":"McLendon","year":"2009","journal-title":"Stem Cells"},{"key":"194","first-page":"6683","article-title":"Human glioblastoma cells release interleukin 6 in vivo and in vitro","volume":"5","author":"de Tribolet","year":"1990","journal-title":"Cancer Res"},{"key":"195","first-page":"367","article-title":"Acute phase response in patients undergoing lumbar spinal surgery: modulation by perioperative treatment with naproxen and famotidine","volume":"1","author":"Sebasti\u00e1n","year":"2004","journal-title":"Eur Spine J"},{"key":"196","first-page":"721","article-title":"Analysis of elevated serum interleukin-6 levels in rheumatoid arthritis: correlation with erythrocyte sedimentation rate or C-reactive protein","volume":"12","author":"Lindsley","year":"1994","journal-title":"J Lab Clin Med"},{"key":"197","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1101\/gad.1890510","article-title":"Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma","volume":"2","author":"Furnari","year":"2010","journal-title":"Genes Dev"},{"key":"198","first-page":"748","article-title":"Erlotinib in glioblastoma: lost in translation?","volume":"1","author":"Halatsch","year":"2011","journal-title":"Anticancer Agents Med Chem"},{"key":"199","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1021\/acs.jmedchem.5b01718","article-title":"Repurposing the Clinically Efficacious Antifungal Agent Itraconazole as an Anticancer Chemotherapeutic","volume":"5","author":"Hadden","year":"2016","journal-title":"J Med Chem"},{"key":"200","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3332\/ecancer.2015.521","article-title":"Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent","volume":"9","author":"Sukhatme","year":"2015","journal-title":"Ecancermedicalscience"},{"key":"201","doi-asserted-by":"publisher","first-page":"e0116390","DOI":"10.1371\/journal.pone.0116390","article-title":"Hedgehog signaling pathway is active in GBM with GLI1 mRNA expression showing a single continuous distribution rather than discrete high\/low clusters","volume":"1","author":"Mukherjee","year":"2015","journal-title":"PLoS One"},{"key":"202","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1007\/s13277-015-3442-y","article-title":"The hedgehog antagonist HHIP as a favorable prognosticator in glioblastoma","volume":"3","author":"Jiang","year":"2016","journal-title":"Tumour Biol"},{"key":"203","doi-asserted-by":"publisher","first-page":"7915","DOI":"10.1038\/srep07915","article-title":"Variant allele frequency enrichment analysis in vitro reveals sonic hedgehog pathway to impede sustained temozolomide response in GBM","volume":"5","author":"Maitra","year":"2015","journal-title":"Sci Rep"},{"key":"204","article-title":"Temozolomide resistance and tumor recurrence: Halting the Hedgehog","volume":"2","author":"Rameshwar","year":"2015","journal-title":"Cancer Cell Microenviron"},{"key":"205","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.ccr.2010.02.027","article-title":"Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth","volume":"1","author":"Epstein","year":"2010","journal-title":"Cancer Cell"},{"key":"206","first-page":"133","article-title":"Essential role of Gli proteins in glioblastoma multiforme","volume":"1","author":"Cascinu","year":"2013","journal-title":"Curr Protein Pept Sci"},{"key":"207","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1007\/s13277-014-2846-4","article-title":"Epigenetic regulation of human hedgehog interacting protein in glioma cell lines and primary tumor samples","volume":"3","author":"Castresana","year":"2015","journal-title":"Tumour Biol"},{"key":"208","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11060-009-0082-3","article-title":"Gli1 inhibition induces cell-cycle arrest and enhanced apoptosis in brain glioma cell lines","volume":"9","author":"Li","year":"2010","journal-title":"J Neurooncol"},{"key":"209","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.canlet.2016.10.034","article-title":"Anti-proliferation of breast cancer cells with itraconazole: Hedgehog pathway inhibition induces apoptosis and autophagic cell death","volume":"38","author":"Zhang","year":"2017","journal-title":"Cancer Lett"},{"key":"210","doi-asserted-by":"publisher","first-page":"28510","DOI":"10.18632\/oncotarget.15324","article-title":"Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K\/mTOR signaling pathways","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"211","first-page":"515","article-title":"Itraconazole Inhibits AKT\/mTOR Signaling and Proliferation in Endometrial Cancer Cells","volume":"3","author":"Sonoda","year":"2017","journal-title":"Anticancer Res"},{"key":"212","doi-asserted-by":"publisher","first-page":"354","DOI":"10.4239\/wjd.v7.i17.354","article-title":"Update on the treatment of type 2 diabetes mellitus","volume":"7","author":"Del Canizo-Gomez","year":"2016","journal-title":"World J Diabetes"},{"key":"213","first-page":"333","article-title":"Metformin: a rising star to fight the epithelial mesenchymal transition in oncology","volume":"1","author":"Rigaud","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"key":"214","doi-asserted-by":"publisher","first-page":"896","DOI":"10.18632\/oncotarget.387","article-title":"Metformin: multi-faceted protection against cancer","volume":"2","author":"Menendez","year":"2011","journal-title":"Oncotarget"},{"key":"215","doi-asserted-by":"publisher","first-page":"40767","DOI":"10.18632\/oncotarget.8194","article-title":"Repurposing metformin for cancer treatment: current clinical studies","volume":"7","author":"Giles","year":"2016","journal-title":"Oncotarget"},{"key":"216","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1136\/amiajnl-2014-002649","article-title":"Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality","volume":"2","author":"Warner","year":"2015","journal-title":"J Am Med Inform Assoc"},{"key":"217","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ctrv.2017.01.005","article-title":"Combination of metformin with chemotherapeutic drugs via different molecular mechanisms","volume":"5","author":"Yang","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"218","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.cmet.2016.09.005","article-title":"Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers","volume":"2","author":"Locasale","year":"2016","journal-title":"Cell Metab"},{"key":"219","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ncb232","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"1","author":"Shaw","year":"2011","journal-title":"Nat Cell Biol"},{"key":"220","first-page":"1","article-title":"Glioblastoma stem cells: a new target for metformin and arsenic trioxide","volume":"2","author":"Valle","year":"2014","journal-title":"J Biol Regul Homeost Agents"},{"key":"221","doi-asserted-by":"publisher","first-page":"811","DOI":"10.5966\/sctm.2012-0058","article-title":"Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK","volume":"1","author":"Kitanaka","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"222","doi-asserted-by":"publisher","first-page":"21315","DOI":"10.18632\/oncotarget.7040","article-title":"Metformin inhibits 17beta-estradiol induced epithelial-to-mesenchymal transition via betaKlotho-related ERK1\/2 signaling and AMPK signaling in endometrial adenocarcinoma cells","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"223","first-page":"2946","article-title":"The impact of metformin and salinomycin on transforming growth factor beta-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cell lines","volume":"1","author":"Zwierzina","year":"2016","journal-title":"Oncol Lett"},{"key":"224","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.bbrc.2014.08.154","article-title":"Metformin inhibits epithelial-mesenchymal transition in prostate cancer cells: involvement of the tumor suppressor miR30a and its target gene SOX4","volume":"45","author":"Han","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"225","doi-asserted-by":"publisher","first-page":"28973","DOI":"10.18632\/oncotarget.5023","article-title":"Metformin represses cancer cells via alternate pathways in N-cadherin expressing vs. N-cadherin deficient cells","volume":"6","author":"Olumi","year":"2015","journal-title":"Oncotarget"},{"key":"226","first-page":"17","article-title":"Metformin Inhibits TGF-\u03b21-Induced Epithelial-to-Mesenchymal Transition via PKM2 Relative-mTOR\/p70s6k Signaling Pathway in Cervical Carcinoma Cells","author":"Hao","year":"2016","journal-title":"Int J Mol Sci"},{"key":"227","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1097\/IGC.0000000000000761","article-title":"Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines","volume":"2","author":"Gotlieb","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"228","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.3892\/ijo.2016.3676","article-title":"Metformin inhibits the radiation-induced invasive phenotype of esophageal squamous cell carcinoma","volume":"4","author":"Tajima","year":"2016","journal-title":"Int J Oncol"},{"key":"229","doi-asserted-by":"publisher","first-page":"61890","DOI":"10.18632\/oncotarget.11301","article-title":"Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells","volume":"7","author":"Taddei","year":"2016","journal-title":"Oncotarget"},{"key":"230","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.3892\/ijo.2016.3419","article-title":"Drug resistance originating from a TGF-beta\/ FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation","volume":"4","author":"Takiguchi","year":"2016","journal-title":"Int J Oncol"},{"key":"231","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.3892\/or.2015.4191","article-title":"Clinicopathological significance of N-cadherin and VEGF in advanced gastric cancer brain metastasis and the effects of metformin in preclinical models","volume":"3","author":"Yang","year":"2015","journal-title":"Oncol Rep"},{"key":"232","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1080\/15384101.2016.1191706","article-title":"Metformin is also effective on lactic acidosis-exposed melanoma cells switched to oxidative phosphorylation","volume":"1","author":"Calorini","year":"2016","journal-title":"Cell Cycle"},{"key":"233","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13045-016-0253-6","article-title":"Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models","volume":"9","author":"Zhu","year":"2016","journal-title":"J Hematol Oncol"},{"key":"234","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1080\/15384101.2016.1152432","article-title":"Metformin attenuates transforming growth factor beta (TGFbeta) mediated oncogenesis in mesenchymal stem-like\/claudin-low triple negative breast cancer","volume":"1","author":"Thor","year":"2016","journal-title":"Cell Cycle"},{"key":"235","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.1007\/s13277-015-3315-4","article-title":"Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway","volume":"3","author":"Fan","year":"2015","journal-title":"Tumour Biol"},{"key":"236","doi-asserted-by":"publisher","first-page":"e95884","DOI":"10.1371\/journal.pone.0095884","article-title":"Metformin inhibits the IL-6-induced epithelial-mesenchymal transition and lung adenocarcinoma growth and metastasis","volume":"9","author":"He","year":"2014","journal-title":"PLoS One"},{"key":"237","doi-asserted-by":"publisher","first-page":"24061","DOI":"10.18632\/oncotarget.4448","article-title":"Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread","volume":"6","author":"Chiarugi","year":"2015","journal-title":"Oncotarget"},{"key":"238","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1158\/1078-0432.CCR-13-2613","article-title":"Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal","volume":"2","author":"He","year":"2014","journal-title":"Clin Cancer Res"},{"key":"239","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11010-013-1845-x","article-title":"Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells","volume":"38","author":"He","year":"2014","journal-title":"Mol Cell Biochem"},{"key":"240","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.1158\/0008-5472.CAN-14-0135","article-title":"AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-Foxo3a signaling axis","volume":"7","author":"Chen","year":"2014","journal-title":"Cancer Res"},{"key":"241","first-page":"1527","article-title":"Metformin upregulates E-cadherin and inhibits B16F10 cell motility, invasion and migration","volume":"1","author":"Lu","year":"2015","journal-title":"Oncol Lett"},{"key":"242","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3109\/0886022X.2016.1149770","article-title":"Metformin alleviated EMT and fibrosis after renal ischemia-reperfusion injury in rats","volume":"3","author":"Liu","year":"2016","journal-title":"Ren Fail"},{"key":"243","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/j.ajpath.2015.04.014","article-title":"Activation of AMP-activated protein kinase prevents TGFbeta induced epithelial-mesenchymal transition and myofibroblast activation","volume":"18","author":"Abboud","year":"2015","journal-title":"Am J Pathol"},{"key":"244","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1124\/mol.115.099549","article-title":"AMPK Inhibits the Stimulatory Effects of TGF-beta on Smad2\/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition","volume":"8","author":"Luo","year":"2015","journal-title":"Mol Pharmacol"},{"key":"245","doi-asserted-by":"publisher","first-page":"8249","DOI":"10.1007\/s13277-015-4639-9","article-title":"LKB1\/AMPK inhibits TGF-\u03b21 production and the TGF-\u03b2 signaling pathway in breast cancer cells","volume":"3","author":"Luo","year":"2016","journal-title":"Tumour Biol"},{"key":"246","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3892\/ijmm.2014.1707","article-title":"Increased FoxM1 expression is a target for metformin in the suppression of EMT in prostate cancer","volume":"3","author":"Tang","year":"2014","journal-title":"Int J Mol Med"},{"key":"247","first-page":"17","article-title":"Metformin plus PIAF combination chemotherapy for hepatocellular carcinoma","volume":"3","author":"Cristea","year":"2012","journal-title":"Exp Oncol"},{"key":"248","first-page":"502","article-title":"Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cells","volume":"1","author":"Kacso","year":"2014","journal-title":"J BUON"},{"key":"249","first-page":"282","article-title":"Metformin plus temozolomide-based chemotherapy as adjuvant treatment for WHO grade III and IV malignant gliomas","volume":"1","author":"Florian","year":"2011","journal-title":"J BUON"},{"key":"250","first-page":"2792","article-title":"Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells","volume":"1","author":"Xie","year":"2016","journal-title":"Oncol Lett"},{"key":"251","first-page":"1","article-title":"Glioblastoma stem cells: a new target for metformin and arsenic trioxide","volume":"2","author":"Valle","year":"2014","journal-title":"J Biol Regul Homeost Agents"},{"key":"252","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1080\/15384101.2016.1186316","article-title":"Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-beta","volume":"1","author":"Bogdahn","year":"2016","journal-title":"Cell Cycle"},{"key":"253","doi-asserted-by":"publisher","first-page":"e0123721","DOI":"10.1371\/journal.pone.0123721","article-title":"Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response","volume":"1","author":"Skuli","year":"2015","journal-title":"PLoS One"},{"key":"254","doi-asserted-by":"publisher","first-page":"78787","DOI":"10.18632\/oncotarget.12859","article-title":"Metformin treatment reduces temozolomide resistance of glioblastoma cells","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"255","doi-asserted-by":"publisher","first-page":"8250","DOI":"10.18632\/oncotarget.14159","article-title":"Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation","volume":"8","author":"Seliger","year":"2017","journal-title":"Oncotarget"},{"key":"256","first-page":"956","article-title":"Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide","volume":"6","author":"Okopie\u0144","year":"2010","journal-title":"Pharmacol Rep"},{"key":"257","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2165\/11588310-000000000-00000","article-title":"Establishment of a database of metformin plasma concentrations and erythrocyte levels in normal and emergency situations","volume":"3","author":"Lacroix","year":"2011","journal-title":"Clin Drug Investig"},{"key":"258","first-page":"3351","article-title":"Effects of metformin treatment on glioma induced brain edema","volume":"8","author":"Liu","year":"2016","journal-title":"Am J Transl Res"},{"key":"259","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"37","author":"Pereira","year":"2014","journal-title":"N Engl J Med"},{"key":"260","first-page":"S405","article-title":"Quetiapine: efficacy and tolerability in schizophrenia","volume":"1","author":"Heiden","year":"2001","journal-title":"Eur Neuropsychopharmacol"},{"key":"261","first-page":"496","article-title":"Rifampicin in non-tuberculous infections","volume":"28","author":"Hamilton-Miller","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"262","first-page":"849","article-title":"Rifampin is a selective, pleiotropic inducer of drug metabolism genes in human hepatocytes: studies with cDNA and oligonucleotide expression arrays","volume":"29","author":"Flockhart","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"263","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40256-016-0200-5","article-title":"Clinical Pharmacology and Cardiovascular Safety of Naproxen","volume":"1","author":"Weisman","year":"2017","journal-title":"Am J Cardiovasc Drugs"},{"key":"264","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1517\/17425255.2013.794785","article-title":"Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections","volume":"9","author":"Hope","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"265","first-page":"691","article-title":"A retrospective chart review of uncontrolled use of metformin as an add-on therapy in type 2 diabetes","volume":"2","author":"Laraway","year":"1998","journal-title":"Clin Ther"},{"key":"266","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.2174\/0929867311320260011","article-title":"Development of therapeutics for high grade gliomas using orthotopic rodent models","volume":"2","author":"Frosina","year":"2013","journal-title":"Curr Med Chem"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T14:32:59Z","timestamp":1597674779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,1]]},"references-count":266,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2017,9,5]]}},"alternative-id":["18337","28977822"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.18337","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,1]]}}}